Craig A. Collard, Director at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 3,706 shares at $18.13 ($67K) on 2021-09-13, disclosed to the SEC on 2021-09-15.
Open-market purchase of $67k OPNT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.96 | 506 | $9K | 13.6% |
| 2 | $18.07 | 700 | $13K | 18.9% |
| 3 | $18.13 | 2,500 | $45K | 67.6% |
| Total | $18.10 avg | 3,706 | $67K | 100% |
| Filing → |
| OPNT | BUY | 2022-05-17 | $368K | — | Filing → |
| OPNT | BUY | 2022-05-16 | $39K | — | Filing → |
| SRRA | BUY | 2021-11-24 | $622K | — | Filing → |